Literature DB >> 19823186

Association between human adenovirus-36 and lipid disorders in Korean schoolchildren.

H-N Na1, Y-M Hong, J Kim, H-K Kim, I Jo, J-H Nam.   

Abstract

BACKGROUND: Although the human adenovirus-36 (Ad-36) has been associated with obesity and related lipid disorders in the United States, this association has yet to be identified in other countries. Therefore, we tried to determine whether Ad-36 is associated with obesity or lipid disorders in Korean schoolchildren.
METHOD: A total of 318 Korean schoolchildren aged 6-15 years, who participated in the Ewha Womans University Obesity Research Study, were selected for a community-based cohort study. Non-obese and obese were defined as body mass index (BMI) <85th and > or = 95th percentiles of the Korean reference BMI-for-age curves, respectively, according to International Obesity Task Force definitions. The cutoff points for lipid disorders were modified from the age-modified standards of the National Cholesterol Education Program (NCEP)-Adult Treatment Panel (ATP) III metabolic syndrome criteria. The Ad-36 antibody was measured using a serum neutralization assay.
RESULTS: More obese participants than non-obese participants tested positive for the Ad-36 antibody (28.57 vs 13.56%, respectively; P = 0.0174). Within the obese group, the participants who tested positive for the Ad-36 antibody had higher levels of triglycerides (TG) and total cholesterol than those who tested negative for the Ad-36 antibody (P<0.001). However, these associations were not present in the non-obese group. The unadjusted odds ratio (OR) for Ad-36 antibody positivity was greater in obese participants than non-obese participants (OR = 2.550, 95% confidence interval (CI): 1.154-5.633). However, this OR seemed to be nonsignificant when age, sex and lipid variables were included in the analysis (OR = 1.752, 95% CI: 0.763-4.020). The unadjusted OR for the elevated TG was significantly higher in participants who were Ad-36 antibody-positive than those who were Ad-36 antibody-negative (OR = 2.511, 95% CI: 1.448-4.353). This trend remained constant even after adjustment for age, sex and obesity (OR = 2.328, 95% CI: 1.296-4.181).
CONCLUSION: Ad-36 seems to be strongly associated with lipid disorders in Korean schoolchildren regardless of obesity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19823186     DOI: 10.1038/ijo.2009.207

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  29 in total

Review 1.  Infectious and Environmental Influences on the Obesity Epidemic.

Authors:  Lili Huo; Jasmine Lyons; Dianna J Magliano
Journal:  Curr Obes Rep       Date:  2016-09

2.  Adenovirus 36 antibody detection: Improving the standard serum neutralization assay.

Authors:  Cynthia L Chappell; Mary Dickerson; R Sue Day; Olga Dubuisson; Nikhil V Dhurandhar
Journal:  J Virol Methods       Date:  2016-11-05       Impact factor: 2.014

3.  Characteristics of adipose tissue macrophages and macrophage-derived insulin-like growth factor-1 in virus-induced obesity.

Authors:  S Park; H-L Park; S-Y Lee; J-H Nam
Journal:  Int J Obes (Lond)       Date:  2015-09-23       Impact factor: 5.095

4.  Adenovirus 36, adiposity, and bone strength in late-adolescent females.

Authors:  Emma M Laing; Ralph A Tripp; Norman K Pollock; Clifton A Baile; Mary Anne Della-Fera; Srujana Rayalam; Stephen M Tompkins; Deborah A Keys; Richard D Lewis
Journal:  J Bone Miner Res       Date:  2013-03       Impact factor: 6.741

5.  Association of adenovirus 36 infection with adiposity and inflammatory-related markers in children.

Authors:  P K Berger; N K Pollock; E M Laing; S J Warden; K M Hill Gallant; D B Hausman; R A Tripp; L D McCabe; G P McCabe; C M Weaver; M Peacock; R D Lewis
Journal:  J Clin Endocrinol Metab       Date:  2014-06-13       Impact factor: 5.958

6.  Longitudinal investigation of adenovirus 36 seropositivity and human obesity: the Cardiovascular Risk in Young Finns Study.

Authors:  M A Sabin; D Burgner; R L Atkinson; Z Pei-Lun Lee; C G Magnussen; M Cheung; M Kähönen; T Lehtimäki; E Jokinen; T Laitinen; N Hutri-Kähönen; J S A Viikari; M Juonala; O T Raitakari
Journal:  Int J Obes (Lond)       Date:  2015-06-09       Impact factor: 5.095

7.  Infectivity period of mice inoculated with human adenoviruses.

Authors:  Rashmi Krishnapuram; Heather Kirk-Ballard; Aamri Zuberi; Nikhil V Dhurandhar
Journal:  Lab Anim       Date:  2011-01-21       Impact factor: 2.471

8.  Exacerbation of chronic inflammatory diseases by infectious agents: Fact or fiction?

Authors:  Cheng-Ming Wang; Bernhard Kaltenboeck
Journal:  World J Diabetes       Date:  2010-05-15

9.  Adenovirus-36 antibody status & BMI comparison among obese Missouri adolescents.

Authors:  Aneesh K Tosh; Amelia Broy-Aschenbrenner; Jasmine El Khatib; Bin Ge
Journal:  Mo Med       Date:  2012 Sep-Oct

10.  Adenovirus 36 DNA in adipose tissue of patient with unusual visceral obesity.

Authors:  Behrouz Salehian; Stephen J Forman; Fouad R Kandeel; Denise E Bruner; Jia He; Richard L Atkinson
Journal:  Emerg Infect Dis       Date:  2010-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.